Facilitated By

San Antonio Medical Foundation

News

  • Breast cancer researcher receives outstanding investigator award - Healio

    SAN ANTONIO — Christina Curtis, PhD, MSc, received this year's AACR ... The work can be conducted in any biomedical research discipline, including ...

  • Io Therapeutics, Inc., announces presentation of data from studies of its RAR gamma agonist ...

    ... San Antonio Breast Cancer Symposium 2024, currently underway in San Antonio, Texas. ... Editorial · Sarepta, Biotech's Regulatory Go-Getter, Signs ...

  • Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as ...

    ... San Antonio Breast Cancer Symposium (SABCS) today, Wednesday, December ... Harnessing the power of biotechnology, chemistry and genetic ...

  • ICAD, Inc. Announces Presentation Of Four Novel AI-Driven Breast Cancer Research ...

    ... Biotechnology Stocks · Blockchain Stocks · Bullish Moving Averages · Bearish ... San Antonio Breast Cancer Symposium. These studies emphasize ...

  • Menarini Group and MEDSIR Present the Phase III Study ADELA - BioSpace

    The study was presented by the Menarini Group and MEDSIR at the San Antonio ... Sarepta, Biotech's Regulatory Go-Getter, Signs Standout Rare ...